Multiple myeloma Archives

PD-1 Antibody Targeting Immune Checkpoint Inhibitor

News & Features

Pfizer Unveils Priorities for Its New Oncology Organization

Malorye Branca -

March 6, 2024

News & Features

How Obesity and Physical Activity Affect Multiple Myeloma Risk

Malorye Branca -

January 17, 2024

Micrograph of multiple myeloma neoplasm from bone marrow biopsy

News & Features

Researchers Unveil Individual Risk Prediction Model for Multiple Myeloma

Alisa Kirkin -

January 10, 2024

News & Features

AstraZeneca Acquires CAR-T Firm Gracell in $1.2B Deal

Malorye Branca -

December 27, 2023

Selective and soft focus of red allergy spots and skin inflammation on child's feet

News & Features

Two-Pronged Approach Tackles Allergies

Anita Chakraverty -

December 14, 2023

Micrograph of myeloma neoplasm from bone marrow biopsy. Multiple myeloma

News & Features

Interactions Between Tumor Genes and Microenvironment Influence Multiple Myeloma Treatment Response

Chris Anderson -

November 15, 2023

CRISPR-enhanced T-cells attacking a tumor

News & Features

Genetic Regulator Supercharges Cancer-Killing T Cells

Anita Chakraverty -

November 9, 2023

News & Features

Diabetes Fuels Multiple Myeloma with Survival Differences Between White and Black Patients

Chris Anderson -

October 11, 2023

News & Features

Scientists Improve Anti-Tumor Power of CAR-T Cells

Alisa Kirkin -

September 22, 2023

News & Features

Charging to the Frontline

Chris Anderson -

August 9, 2023

12 3...5 Page 1 of 5

Vitamin D May Improve Cancer Immunity by Altering the Gut Microbiome

Do COVID-19 mRNA Vaccines Boost Mucosal Immunity?

Pandemic Preparedness Needs Genomic Surveillance

Walgreens Dives into Gene and Cell Therapy Delivery

A Newly Discovered Tumor Mechanism Could Improve Immunotherapies

Multiple myeloma

Pfizer Unveils Priorities for Its New Oncology Organization

How Obesity and Physical Activity Affect Multiple Myeloma Risk

Researchers Unveil Individual Risk Prediction Model for Multiple Myeloma

AstraZeneca Acquires CAR-T Firm Gracell in $1.2B Deal

Two-Pronged Approach Tackles Allergies

Interactions Between Tumor Genes and Microenvironment Influence Multiple Myeloma Treatment Response

Genetic Regulator Supercharges Cancer-Killing T Cells

Diabetes Fuels Multiple Myeloma with Survival Differences Between White and Black Patients

Scientists Improve Anti-Tumor Power of CAR-T Cells

Charging to the Frontline

Related Content

Removing Notch Ligand, Jagged2, Rewires the Immune System to Eliminate NSCLC

Breakthrough Imaging Approved for Residual Breast Cancer Detection after Lumpectomy

Tetracycline Antibiotics Pinpoints Targets for Novel Cancer Immunotherapies

AI Algorithm Could Reduce Breast Cancer Mammogram False Positive Rate